Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy

BACKGROUND: Ductal adenocarcinoma of the pancreas (PDAC) remains one of the most lethal malignancies. To date, no guidelines exists for isolated resectable metachronous disease. It is still unknown, which patients may benefit from relapse surgery. The aim of our study was to compare disease free sur...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Surg
Main Authors: Safi, S. A., Lehwald-Tywuschik, N., Rehders, A., Fluegen, G., Haeberle, L., Keitel, V., Knoefel, W. T.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931536/
https://ncbi.nlm.nih.gov/pubmed/33658016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12893-021-01082-w
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki